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Abstract
Antiretroviral therapy is a drug treatment that plays a great role in reduc-
tion of mortality among children infected with human immunodeficiency virus 
(HIV). Studies in Africa have shown that there is short survival time among 
children receiving antiretroviral therapy. The aims of this study were to estimate 
the survival time and identify associated factors among HIV-infected children 
after initiation of antiretroviral therapy. Institution-based retrospective cohort 
study was conducted among 421 children. Cox proportional hazards regression 
model was used to determine independent predictors. Findings of this study 
reveal that 261 (62%) children were alive, 43 (10.2%) were lost to follow-up, 52 
(12.4%) were transferred out to other facilities, and 65 (15.4%) were reported 
to have died, and overall prevalence of malnutrition among respondents was 
23.7% (95% CI, 19.13–28.27%). Multivariable analysis showed that nutritional 
status (adjusted hazard ratio (AHR) = 4.1, 95% CI = 2.41–6.9), absolute CD4 
count below threshold (AHR = 2.3, 95% CI = 1.32–3.88), fair and poor adher-
ence to antiretroviral therapy (AHR = 0.4, 95% CI = 1.66–6.9), (AHR = 3.3, 95% 
CI = 1.73–6.23), isoniazid prophylaxis (AHR = 0.4, 95%, CI = 0.21–0.65), and 
co-trimoxazole prophylaxis (AHR = 0.3, 95% CI = 0.14–0.44) were independent 
predictors of the survival time. Therefore, children living with HIV should be 
encouraged to adhere to the antiretroviral therapy and take co-trimoxazole and 
isoniazid preventive therapies.
Keywords: antiretroviral therapy, co-trimoxazole preventive therapy,  
isoniazid preventive therapy, children, Ethiopia
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1. Introduction
Acquired immune deficiency syndrome (AIDS) is a disease caused by a retro-
virus known as human immunodeficiency virus (HIV) [1]. HIV/AIDS remains one 
of the world’s most significant public health challenges, particularly in low- and 
middle-income countries [2]. Children constitute a segment of the population 
affected by the virus. HIV contributes to illness and death of children and is the 
commonest cause for pediatric hospital admission [3].
Of the total 1.8 million children living with HIV, an estimated 110,000 die of 
AIDS-related illnesses each year which means 290 children die of AIDS-related 
illnesses every day. Nearly 90% of HIV-infected children live in sub-Saharan Africa 
(SSA) [4]. In Ethiopia it is estimated that 65,088 children are living with HIV. In 
2016, over 3100 children died due to AIDS-related illness [5].
The introduction of antiretroviral therapy (ART) presented an enormous 
opportunity in terms of reducing morbidity and mortality due to AIDS, worldwide. 
Ethiopia has been engaged in the scale-up of ART access to its people since 2005 [6]. 
It has been shown that the improvement in access to ART improves the quality of 
life and survival of children [7, 8].
Studies show that early access to ART could prevent 25% of HIV-related deaths 
[7–9]. Therefore, to reduce child mortality attributed to HIV/AIDS, the provision 
of comprehensive treatment, care, and support for HIV-infected children is very 
important.
Ethiopia has adopted the World Health Organization’s (WHO) recommenda-
tions for ART where “regardless of their CD4 cell count, all HIV-infected individu-
als should start treatment to reduce morbidity and mortality associated with HIV 
infection” [3]. The number of sites providing ART service in Ethiopia, including 
both public and private facilities, has increased from 3 to over 1000, and persons 
initiated on treatment has increased from 24,000 to 308,000 during the period 
2006–2016 with more than 23,400 children under the age of 15 taking antiretroviral 
drugs [10].
Survival of HIV-positive children in Ethiopia and other similar settings has 
improved as a result of increased access to ART; however, it is still low in the 
first 6 months after initiation of ART [11]. Reports from Kenya, Zambia, and 
Malawi show that death among HIV-positive children following ART initiation 
remains high, ranging from 7.5 to 15% [12–14]. This contrasts the substantially 
higher survival probability among HIV-positive children initiated on ART in 
developed countries [15]. Findings from other studies elsewhere in Africa and 
other low-income countries show that ART programs have resulted in decreased 
mortality among children on ART [16–18]. Available evidences also depicted 
that the survival of the children is not only affected by the care delivered by 
ART programs but also more fundamentally influenced by low CD4 count, 
advanced disease according to WHO staging, low hemoglobin (Hgb) level, 
and opportunistic infections (OIs) like bacterial pneumonia and tuberculosis 
[19–21]. However, as far as our search of the available literature has revealed, 
little is known about the effect of factors like viral load, nutritional status, co-
trimoxazole (CTZ) preventive therapy (CPT), and isoniazid (INH) preventive 
therapy (IPT) on survival status of children below 15 years of age. Therefore, 
this study intended to estimate the survival time and identify associated factors 
by including viral load, nutritional status, CPT, and IPT among HIV-infected 
children initiated on ART in public health facilities in Arba Minch town, 
Southern Ethiopia.
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2. Main body
2.1 Patients and methods
Study area and period: We conducted the study in Arba Minch town from March 
20, 2017 to April 10, 2017. Arba Minch town is located about 495 km southwest of 
the capital city Addis Ababa and about 275 km from Hawassa, the capital of the 
Southern Nations, Nationalities, and Peoples’ Region (SNNPR). Arba Minch town 
has one general hospital and one public health center, which provide ART service. 
Arba Minch Hospital was among the first few public hospitals to start ART in 
Ethiopia in August 2003. Arba Minch Health Center started ART service at the end 
of 2007. According to the Gamo Gofa Zone Health Department (ZHD) report, the 
Arba Minch Hospital and Arba Minch Health Center provide HIV/AIDS interven-
tions, including free diagnostic, treatment, and monitoring services. Since August 
2003, ART has been provided to children living with HIV regardless of CD4 count 
and WHO clinical stage, with financial support from the Norwegian Lutheran 
Mission. Data from ZHD show that a total of 664 children with HIV/AIDS were 
enrolled on chronic HIV care at the hospital and the health center since January 
2009, but only 608 started ART (460 children at Arba Minch General Hospital and 
148 children at Arba Minch Health Center) [22].
Study design: A health facility-based retrospective cohort study.
Source populations: All children living with HIV who were enrolled on first-
line ART at the center.
Study populations: All children living with HIV who were enrolled on first-line 
ART at the center and who fulfill the inclusion criteria.
Inclusion criteria: Those who were aged <18 years and enrolled on first-line 
ART and have follow-up at Arba Minch General Hospital and Health Center.
Sample size determination: The sample size was calculated by applying a 
two-population proportion formula using Epi-Info version 7. Co-trimoxazole 
preventive therapy, tuberculosis (TB) co-infection at baseline, and anemia were 
considered, and taking the most significant predictors of the three variables, 
anemia was used [17] with the following assumptions: 95% CI, power 80%, 
ratio of unexposed to exposed 1:1, parameter outcome in exposed hemoglobin 
(Hgb) < 10 gm/dl = 14.7%, outcome in unexposed Hgb ≥ 10 gm/dl = 5.8%, and 
hazard ratio (HR) = 2.5. This resulted in sample size of 412 children. As there were 
a total of 421 children in the study area who fulfilled the inclusion criteria, we 
included all 421 in this study.
Sampling procedure and sampling technique: A total of 608 children who started 
ART during the study period were identified in the two ART clinics. Charts were 
organized according to the hospital card number, in a chronological order, with 
each chart representing one child. As some of the charts in the hospital were not 
arranged in numerical order, the investigator assigned new numbers for all those 
registered between 2009 and 2016, starting from 1 to 608. Of these, the investigator 
drew 421 samples which fulfilled the inclusion criteria after reviewing the informa-
tion transcribed to the pre-structured data abstraction form; 187 individuals did not 
fulfill the inclusion criteria; therefore, those charts were excluded from the study. 
Children ≤14 years of age and on ART registered for chronic care at public health 
institutions of Arba Minch town from 1 January 2009 to 30 December 2016 were 
included in the study. Those whose cards were incomplete with information on 
baseline CD4 count, WHICH staging and date of ART start and current status were 
excluded from the study.
Nutrition and HIV/AIDS - Implication for Treatment, Prevention and Cure
4
2.2 Variables in the study
Dependent variable: The response (outcome) variable in this study was “survival 
time” of HIV-infected children after starting ART.
Independent variables: The predictor variables included five continuous covari-
ates (age, hemoglobin level, weight, height, and CD4 count) and nine categorical 
variables (gender, co-trimoxazole prophylaxis, TB co-infection status, isoniazid 
prophylaxis, functional status, clinical stage of the disease according to WHO scal-
ing, type of ART drug, adherence to ART, and year of ART initiation).
2.3 Operational definition of terms
Censored: includes lost to follow-up, transfer out, and live beyond the study time.
Adherence to ART: assessed by counting the number of tablets the children miss 
within the first 3 months after starting ART.
Survival: absence of experience of death.
Survival time: the length of time in months a child was followed up from the time 
the child started ART until death, was lost to follow-up, or was still on follow-up.
3. Data collection procedure and data quality control
A structured interviewer-administered questionnaire was used to collect the 
data [23–25]. The questionnaire was primarily developed in English and then 
translated into Amharic language for simplicity of data collection. Then Amharic 
version was also back-translated to English language for its consistency by two 
different language experts. The data collection tool has four sections. Pretesting of 
the data collection tool was done on 17 individuals who were selected from Berber 
Health Center that were not included in the actual study. Based on the pretest, a 
data collection tool was corrected to ensure logical sequence, clarity, and skipping 
patterns. Data was collected by eight trained health professionals and supervised 
by two bachelor degree health professionals. All data collectors and supervisors 
were trained for 2 days and performed practical exercises to be familiar with the 
questionnaire. Exit interview was done. The participants’ weight was measured in 
kilograms with 0.2 kg increments using standard beam balance, and the scale was 
checked at zero during measurement. The study participant was removing their 
heavy outer clothes and shoes. The participant height was measured using the stan-
dard measuring scale to the nearest 0.5 cm. The participants were asked to take off 
their shoes, stand erect, and look straight in vertical plain. The data collectors were 
regularly supervised for proper data collection as well as checked for completeness 
and consistency throughout data collection period.
Data processing and analysis: The completeness and consistency of the data 
was checked, coded, and double entered into Epi-info version 7 and exported to 
Statistical Package for Social Sciences (SPSS) version 20 for analysis. Exploratory 
data analysis was carried out to check the levels of missing values and presence 
of influential outliers. Descriptive statistics such as mean (standard deviation), 
frequencies, and proportions were used to describe the characteristics of the cohort. 
Kaplan-Meier survival curve together with log-rank test was used to assess survival 
experience of an individual at specific times and to compare survival between dif-
ferent independent variables.
The analysis was conducted in several steps. First, univariate Cox propor-
tional hazard regression model was performed for each independent variable 
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and outcome of interest to identify potentially significant variables for consid-
eration in the multivariable Cox proportional hazards regression model. Based 
on the univariate analysis, variables were selected for the multivariable analysis. 
Variables whose univariate significance test results were below p-value <0.25 
were included in the multivariable regression model. In addition, context and 
findings of previous studies were considered in the identification of candidate 
variables for multivariable analysis.
Multivariable analysis was started with a model containing all of the selected 
variables. The model was built through a stepwise regression procedure, which 
added variables successively (the most significant at each step) until no variable 
added significant information and compared by likelihood ratio test and Harrell’s 
concordance statistic test. Interactions and confounders were tested and the cutoff 
point of beta change greater than 20% was used. The results of the final model were 
expressed in terms of hazard ratio with 95% confidence intervals (CI) and inter-
preted accordingly. Kaplan-Meier survival curve together with log-rank test was 
used to check for the existence of any significant differences in survival between the 
various categories of variables considered in this study. Statistical significance was 
declared if the p-value was less than 0.05.
Ethical considerations: Ethical approval was obtained from the ethical review 
committee of Arba Minch University, College of Medicine and Health Sciences, 
with reference number CMHS/4268/09. Following the approval, an official letter 
of cooperation was written to concerned bodies by the Department of Public 
Health of Arba Minch University. Permission was granted from the Hospital 
and Health Center Administration as per the recommendation letter from the 
department. Personal identifiers were excluded during data extraction; rather 
codes were used. Considering the study was being conducted on secondary data, 
obtaining informed consents from the participants was not possible. However, the 
confidentiality of information was maintained by not recording their name from 
the chart, and the recorded data were not accessed by a third person except by the 
principal investigator.
4. Results
Baseline characteristics of the study participant: A total of 421 study participants 
(children under 15 years old) were included in the study. The sample is comprised 
of 241 (57.2%) males and 180 (42.8%) females. The ages of the cohort at ART 
initiation ranged from 3 to 168 months with a median age of 72 (IQR = 33–108) 
months. Based on WHO clinical staging, 196 (47%) children initiated ART at an 
advanced stage of the disease, i.e., WHO clinical stage III or IV. During the ART 
initiation, 139 (33%) children were affected by one or more opportunistic ill-
ness, of which 41 children were found to have died at the end of the study. Sixty 
(14.3%) had history of TB at the start of ART, and 36 died during the follow-up 
time. At the initiation of ART, mean (SD) value for weight of children was 18.6 
(±9.65) kg, and mean (SD) value for height of the cohort was 110.8 (±32.19) 
cm. The baseline median value for Hgb was 10.9 (IQR = 8.8–12.3) g/dl, and 181 
(43.1%) of the children had absolute CD4 count below threshold for immune 
deficiency at initiation of ART.
Among the reviewed participants, 410(97.4%) were on first-line ART regimen, 
while the rest were started on second line. Concerning the type of ART regimens, 
around 61% of children were taking D4T-based drug regimens when they started 
the treatment (Table 1).
Nutrition and HIV/AIDS - Implication for Treatment, Prevention and Cure
6
5. Mean survival time after initiation of ART
After initiation of ART, children were followed up for a minimum of 1 and maxi-
mum of 95 months with median follow-up period of 50 (IQR = 24–80) months. At 
the end of follow-up, 261 (62%) of the children were alive, 43 (10.2%) were lost to 
follow-up, 52 (12.4%) were transferred out to other facilities, and 65 (15.4%) were 
reported dead. The overall mean estimated survival time after ART initiation of 
children in the study was 82.3 (95% CI = 79.48–85.14) months.
There is a significantly different survival time between different factors con-
sidered in this study. Females have relatively lower survival time of 79.3 months 
than males with 84.6 months. Children 1–4 years of age had higher survival time of 
86.8 months than those less than 1 and 5–14 years of age who had a mean survival 
time of 69.3 and 80.8 months, respectively.
Variables Categories Frequency Percent
Sex Male 241 57.2
Female 180 42.8
Age category <1 year 30 7.1
1–4 years 169 40.1
5–14 years 222 52.7
Primary caregiver Parents 268 63.7
Relatives 119 28.3
Guardian/orphan 34 8.0
Parental status Both parents are alive 260 61.8
Maternal orphan 45 10.9
Paternal orphan 31 7.4
Double orphan 84 19.9
WHO clinical staging at entry Stage I 91 21.6
Stage II 135 32.1
Stage III 147 34.9
Stage IV 48 11.4
TB at baseline Yes 60 14.3
No 361 85.7
Hemoglobin level at baseline <10 gm/dl 78 18.5
≥10 gm/dl 343 81.5
Absolute CD4 at baseline CD4 above threshold 239 56.9
CD4 below threshold 181 43.1
ART adherence status Good 335 79.6
Fair 33 7.8
Poor 53 12.6
CTZ prophylaxis Yes 314 74.6
No 107 25.4
INH prophylaxis Yes 302 71.7
No 119 28.3
Table 1. 
Demographic and clinical characteristics and chemoprophylaxis status among children on antiretroviral 
treatment at Arba Minch Hospital and Health Center, Southern Ethiopia, 2017.
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6. Comparison of survival curves
The overall Kaplan-Meier survivor function estimate showed that most of the 
deaths occurred in the earlier months of ART initiation, which declined in the later 
months of follow-up. Most of the graphs did not show differences between differ-
ent categories. However, relatively larger gaps are observed in covariates such as 
WHO clinical stage, TB co-infection, low Hgb level (<10gm/dl), and CTZ and INH 
prophylaxes (Figures 1 and 2).
7. Results of the Cox proportional hazards regression model
One important predictor of low survival time in univariable Cox regression 
analysis was advanced WHO staging. The risk of low survival chance in individuals 
with advanced disease according to WHO staging at baseline was nearly 4 times 
Figure 1. 
The plot of the overall estimate of Kaplan-Meier survivor function among children on ART at public health 
facilities of Arba Minch town, Southern Ethiopia, 2017.
Figure 2. 
Survival curves for children on ART by WHO clinical stage, hemoglobin level, and TB co-infection after start 
on ART at public health facilities in Arba Minch town, 2017.
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higher than that of those at the mild stage of the disease (P < 0.001). The risk of 
surviving a shorter time in individuals who had severe acute malnutrition (SAM) at 
baseline was nearly 2.5 times higher when compared to those with no malnutrition 
(P < 0.006). Patients with baseline opportunistic infections (OIs) survive nearly 
three 3 times shorter than those without OIs (P < 0.001), and children with TB 
co-infection were nearly 11 times more likely to survive shorter when compared to 
those without TB co-infection (P < 0.001). The risk of surviving at short duration 
was significantly higher with low hemoglobin level (CHR = 7.3, 95% CI = 4.47–11.9, 
Covariate/factor Categories CHR P-values
Sex Male
Female 1.617 0.053*
Age group <1 year
1–4 years 1.259 0.336
5–14 years 0.655 0.069*
Nutritional status Normal
Underweight 1.903 0.010*
Anemia No
Yes 2.702 0.001*
Absolute CD4 count Above threshold
Below threshold 1.293 0.041*
INH prophylaxis No
Yes 0.408 0.001*
CTZ prophylaxis No
Yes 0.348 0.001*
ART adherence on follow-up Good
Fair 6.256 0.001*
Poor 5.937 0.001*
WHO clinical staging at entry Stage I and II
Stage III 2.360 0.009*
Stage IV 10.412 0.001*
Functional status Working
Ambulatory 1.302 0.350
Bedridden 1.375 0.392
ART regimens at entry D4t-based regimen 0.294 0.420
AZT-based regimen 0.513 0.290
TDF-based regimen 0.562 0.404
Second-line ART
Evidence of TB during follow-up Yes 1.383 0.050*
No
Note: CTZ, Cotrimoxazole; ART, antiretroviral therapy; INH, isoniazid; TB, tuberculosis; OI, opportunistic Infections, 
*p < 0.25 which are candidate for Multivariate Cox regression model.
Table 2. 
Univariable Cox regression analysis of sociodemographic characteristics and clinical and immunological status 
among children who were started on ART at public health facilities of Arba Minch town, 2017.
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P = 0.001) and CD4 count below the threshold (CHR = 1.7, 95% CI = 1.02–2.74, 
P = 0.041) when starting ART compared to their counterparts. CTZ and INH had 
preventive effect against surviving for short duration (CHR = 0.2, 95% CI = 0.10–
0.27 P = 0.001) and (CHR = 0.1, 95% CI = 0.07–0.20 P = 0.001) when compared to 
their counterparts throughout the follow-up period, respectively (Table 2).
In multivariable Cox regression analysis, children with CD4 count below 
threshold for immunodeficiency at ART initiation were 2.3 times (AHR = 2.26, 95% 
CI = 1.32–3.88, P = 0.003) more likely to survive at shorter duration as compared to 
those with CD4 count above threshold. Children with low weight for age (under-
weight) at ART initiation were almost 4 times (AHR = 4.1, 95% CI = 2.41–6.9, 
P = 0.001) more likely to survive at shorter duration as compared to those with 
normal weight. Children that were presented for treatment with fair ART adherence 
and poor ART adherence were on follow-up 3.4 times (AHR = 3.4, 95% CI = 1.66–
6.9, P = 0.001) and 3.3 times (AHR = 3.3, 95% CI = 1.73–6.23, P = 0.001) and more 
likely to survive at shorter duration, respectively, as compared to those with good 
adherence on follow-up. Estimated AHR for children on INH prophylaxis and CTZ 
prophylaxis were 0.4 (95% CI = 0.21–0.65, P = 0.001) and 0.3 (95% CI = 0.14–0.44, 
P = 0.001); short duration survival hazard among children who took INH prophy-
laxis was 63% and CTZ prophylaxis 75% (Table 3).
8. Discussion
In this study the overall mean survival time was 82.3 months (95% CI: 79.48–
85.14). The cumulative probability of survival of children on ART was 82.9% after 
5 years (95% CI: 78.2%–86.7%). The major factors that affect the survival time of 
children with HIV/AIDS and on ART are nutritional status, absolute CD4 count 
below threshold, and poor/fair adherence to ART. Isoniazid prophylaxis and co-
trimoxazole prophylaxis were preventive factors.
Mean survival time in our cohort was 82.3 months (95% CI = 79.48–85.14). 
This was in line with the finding of a study conducted in Southwest Ethiopia 
[83 months (95% CI = 79–87)] [26]. However, our finding was higher when com-
pared with study conducted in Northwest Ethiopia, which reported a survival time 
of 56.5 months [20]. This difference might be associated with the high proportion 
(74.3%) of children in this study taking CTZ prophylaxis as compared to the finding 
Covariate Categories AHR P-values
Nutritional status Normal 1
Underweight 4.08 0.001
Absolute CD4 count Above threshold 1
Below threshold 2.26 0.003
INH prophylaxis No 1
Yes 0.37 0.001
CTZ prophylaxis No 1
Yes 0.25 0.001
ART adherence on follow-up Good 1
Fair 3.39 0.001
Poor 3.28 0.001
Table 3. 
Multivariable Cox regression analysis of sociodemographic characteristics and clinical and immunological 
status among children on ART at public health facilities of Arba Minch town, 2017.
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of the study conducted in Northwest Ethiopia (52.3–70.4%), and the difference 
might also be associated with increased access to ART services.
The cumulative probability of survival of children on ART in our study was 
82.9% after 5 years (95% CI: 78.2–86.7%). This was comparable with the report of 
a study conducted in Felege Hiwot Referral Hospital, Bahir Dar, Northern Ethiopia 
(83%) [27] and another one in Northwest Ethiopia (83%) [20]. However the cumu-
lative survival probability from our study was much lower than that of the reports 
from Adama Referral Hospital and Medical College, Central Ethiopia (91.6%) [19], 
and Wolaita zone health facilities, Southern Ethiopia (92%) [20]. These variations 
between our study and those from central and Southern Ethiopia may have some-
thing to do with the variation in the quality of care provided at different institutions.
In this study we found that having CD4 cell count below the threshold level was sig-
nificantly associated with an increased probability of having short duration of survival 
among the children. This concurs with the findings of different studies previously 
done in Ethiopia [20, 28]. The similarity might be related to the fact that children, in 
our series, with absolute CD4 counts below the threshold level are more prone to OIs 
like TB. Another possible explanation could be ART was initiated in an advanced HIV 
stage (stages III and IV) where immunity of the children was already compromised.
Another covariate that had a significant effect on survival time was adherence 
to ART. The HR for poor adherence was 2.1 times, and the HR for fair adherence 
was 2.2 times more likely to result in short duration of survival compared to chil-
dren with good adherence. This finding was supported by studies conducted in 
Northwest Ethiopia [28] and Wolaita zone health facilities [20]. The poor adherence 
might be due to insufficient counseling and education of caregiver/patient.
The initiation of CTZ and INH at the start of ART in our cohort was associated 
with a longer duration of survival. This finding concurred with that of the studies 
conducted in Felege Hiwot Referral Hospital, Northern Ethiopia [20], and rural 
Mozambique [29]. The possible reason for higher risk of shorter survival time 
among children who did not receive CTZ at ART initiation could be due to occur-
rence of OIs such as Pneumocystis pneumonia, toxoplasmosis, bacterial pneumonia, 
sepsis, and diarrhea. Co-trimoxazole prophylaxis should be given at the initiation 
of ART to reduce OI and associated short duration survival among HIV-positive 
children on ART, thereby improving their survival.
The hazards of short survival time for children on INH prophylaxis was 0.38, 
which means that, in those children who take INH prophylaxis, the hazard of short 
duration of survival was reduced by 62%. This finding corroborates the finding of 
the study conducted in Mizan-Aman General Hospital, in Southern Ethiopia [26], 
and that of a double blinded, placebo-controlled trial on INH efficacy among HIV 
children infected in Cape Town, South Africa [30]. A possible reason could be INH 
prophylactic therapy (IPT) prevented the occurrence of TB.
There are some strengths and limitations of this study. The strengths of this study 
are the use of standard measurements which enabled to make the comparison of 
findings with other national and international literatures to be valid. In addition, 
considering long duration of follow-up period of children on ART and the inclusion 
of important predictors like CTZ, INH and nutritional status also add to the strength 
to this study. Since our study is retrospective based on available records, excluding 
those with incomplete information, survival time might be underestimated.
9. Conclusion
In general, this study showed that the probability of survival of children on ART 
was 73.9% after 96 months and the overall mean survival time was 82.3 months. 
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The main independent predictors of the survival time were nutritional status, 
absolute CD4 count below threshold, poor/fair adherence to ART, and absence 
of INH prophylaxis and CTZ prophylaxis. However, sex, age, advanced disease 
according to WHO clinical stage, and presence of TB at baseline were not predictors 
of survival time. Therefore, children living with HIV should be encouraged to take 
prophylaxis drugs like CTZ and INH. This could be achieved by collective efforts 
of all concerned bodies on high-risk groups such as children with OI especially TB 
after initiation of ART and a careful monitoring and follow-up of the children.
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